4//SEC Filing
Bjork Elisabeth 4
Accession 0001140361-21-021291
CIK 0001281895other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:55 PM ET
Size
7.4 KB
Accession
0001140361-21-021291
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-14$29.42/sh+1,699$49,985→ 1,699 totalExercise: $47.25Exp: 2031-06-14→ Common Stock (1,699 underlying) - Award
Stock Option (Right to Buy)
2021-06-14+12,236→ 12,236 totalExercise: $47.25Exp: 2031-06-14→ Common Stock (12,236 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022.
- [F2]This option represents a right to purchase a total of 1,699 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001810406
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 7:55 PM ET
- Size
- 7.4 KB